Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Josephine M Barbiere"'
Autor:
Georgios Lyratzopoulos, Karen A Wright, C. H. Brown, David E. Neal, C. Palmer, David Greenberg, Josephine M Barbiere
Publikováno v:
Journal of Public Health. 34:108-114
Background To examine associations of private healthcare with stage and management of prostate cancer. Methods Regional population-based cancer registry information on 15 916 prostate cancer patients. Results Compared with patients diagnosed in the N
Autor:
Josephine M Barbiere, M.R. Thompson, Michel P Coleman, Michael Baum, Bernard Rachet, Georgios Lyratzopoulos
Publikováno v:
Annals of Oncology. 22:1661-1666
Background Socioeconomic inequalities in cancer survival are well documented but they vary for different cancers and over time. Reasons for these differences are poorly understood. Patients and methods For England and Wales, we examined trends in soc
Autor:
David M. Greenberg, Karen A Wright, Kelly L. Bolton, Josephine M Barbiere, H. Newsome, Georgios Lyratzopoulos, Henry C Kitchener
Publikováno v:
European Journal of Surgical Oncology (EJSO). 37:435-441
Surveillance of trends in cancer management can help in service evaluation and quality improvement.We used East Anglia cancer registration data from 1995-2006 on 3063 patients with epithelial ovarian cancer. We described treatment patterns and examin
Publikováno v:
Gastroenterology. 137:1869-1876
Screening interventions for Barrett's esophagus (BE) are appealing, but there is little supporting evidence. We reviewed health economics studies about BE endoscopic screening followed by, as required, endoscopic surveillance ("screening and surveill
Autor:
Josephine M Barbiere, Michael McMahon, David Greenberg, Karen A Wright, Georgios Lyratzopoulos
Publikováno v:
Thorax. 66:453-455
Objective To assess time trends in use of surgery in patients with non-small cell lung cancer (NSCLC) in a UK region. Methods Cancer registration data for patients diagnosed with NSCLC between 1995 and 2006 in the East of England were analysed. Rates
Publikováno v:
The Lancet oncology, 2012, Vol.13(4), pp.353-365 [Peer Reviewed Journal]
Background: Information from patient surveys can help to identify patient groups and cancers with the greatest potential for improvement in the experience and timeliness of cancer diagnosis. We aimed to examine variation in the number of pre-referral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414f1faddf6531b0db93650488760613
http://dro.dur.ac.uk/9316/1/9316.pdf
http://dro.dur.ac.uk/9316/1/9316.pdf
Autor:
Gary A. Abel, C. H. Brown, Josephine M Barbiere, Brian Rous, David Greenberg, Georgios Lyratzopoulos
Publikováno v:
British Journal of Cancer
Background: Understanding variation in stage at diagnosis can inform interventions to improve the timeliness of diagnosis for patients with different cancers and characteristics. Methods: We analysed population-based data on 17 836 and 13 286 East of
Autor:
John Campbell, Charlotte Paddison, Marc N. Elliott, Laura Staetsky, Martin Roland, Josephine M Barbiere, Andrew Henderson, Georgios Lyratzopoulos
Publikováno v:
BMJ quality & safety
Background Ethnic minorities and some other patient groups consistently report lower scores on patient surveys, but the reasons for this are unclear. This study examined whether low scores of ethnic minority and other socio-demographic groups reflect
Autor:
Laura Staetsky, Charlotte Paddison, Martin Roland, John Campbell, Josephine M Barbiere, Marc N. Elliott, Georgios Lyratzopoulos
Publikováno v:
Medical care. 49(8)
Patient experience is increasingly used to assess organizational performance, for example in public reporting or pay-for-performance schemes. Conventional approaches using 95% confidence intervals are commonly used to determine required survey sample
Autor:
David Greenberg, Georgios Lyratzopoulos, Karen A Wright, Michael J. C. Rhodes, Chetna Gajperia, Josephine M Barbiere
Publikováno v:
BMC Health Services Research, Vol 9, Iss 1, p 231 (2009)
BMC Health Services Research
BMC Health Services Research
Background Previous evidence indicates potential variation in the quality of care of cancer patients. We aimed to examine whether recent changes in the treatment of oesophagogastric cancers have been distributed equally among different patient subgro